Prohibition Juice fails with court claim that US FDA overstepped its authority

Prohibition Juice has failed in an attempt to get the US Food and Drug Administration (FDA)’s authority over vaping products curtailed. The New York-based e-liquid manufacturer had challenged an FDA market denial order (MDO), asserting that the agency lacked the statutory authority to consider a product’s “relative effectiveness at promoting cessation of combustible cigarette use versus another product with an otherwise similar health risk profile and labelling”.

However, the US Court of Appeals for the District of Columbia Circuit ruled that the FDA did have authority under the Tobacco Control Act to determine whether a product is appropriate for the protection of public health. And that meant an applicant must supply all information concerning investigations which have been made on the health risks of a product, as well as whether a product presents less risk than others.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ Prohibition Juice fails with court claim that US FDA overstepped its authority ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Prohibition Juice fails with court claim that US FDA overstepped its authority ”






      Prohibition Juice has failed in an attempt to get the US Food and Drug Administration (FDA)’s authority over vaping products curtailed. The New York-based e-liquid manufacturer had challenged an FDA market denial order (MDO), asserting that the agency lacked the statutory authority to consider a product’s “relative effectiveness at promoting cessation of combustible cigarette use versus another product with an otherwise similar health risk profile and labelling”.

      However, the US Court of Appeals for the District of Columbia Circuit ruled that the FDA did have authority under the Tobacco Control Act to determine whether a product is appropriate for the protection of public health. And that meant an applicant must supply all information concerning investigations which have been made on the health risks of a product, as well as whether a product presents less risk than others.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik